Montag & Associates’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12
Closed -$1.22K 958
2025
Q4
$1.22K Hold
12
﹤0.01% 910
2025
Q3
$657 Sell
12
-4
-25% -$200 ﹤0.01% 1058
2025
Q2
$851 Hold
16
﹤0.01% 919
2025
Q1
$693 Hold
16
﹤0.01% 975
2024
Q4
$900 Sell
16
-10
-38% -$622 ﹤0.01% 962
2024
Q3
$1.77K Buy
26
+10
+63% +$564 ﹤0.01% 930
2024
Q2
$676 Sell
16
-22
-58% -$1.21K ﹤0.01% 960
2024
Q1
$2.63K Hold
38
﹤0.01% 855
2023
Q4
$2.81K Hold
38
﹤0.01% 853
2023
Q3
$2.59K Hold
38
﹤0.01% 842
2023
Q2
$3.57K Sell
38
-2
-5% -$156 ﹤0.01% 839
2023
Q1
$2.71K Hold
40
﹤0.01% 853
2022
Q4
$1.98K Buy
40
+24
+150% +$981 ﹤0.01% 867
2022
Q3
$1K Hold
16
﹤0.01% 833
2022
Q2
$1K Sell
16
-19
-54% -$1.02K ﹤0.01% 790
2022
Q1
$2K Hold
35
﹤0.01% 782
2021
Q4
$3K Hold
35
﹤0.01% 783
2021
Q3
$3K Sell
35
-20
-36% -$2.11K ﹤0.01% 780
2021
Q2
$7K Sell
55
-1,188
-96% -$142K ﹤0.01% 752
2021
Q1
$164K Buy
1,243
+920
+285% +$126K 0.01% 414
2020
Q4
$43K Buy
+323
New +$39.1K ﹤0.01% 554

Other funds holding EXAS

Montag & Associates's EXAS Position: Q1 2026 in Review

Montag & Associates sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 12 shares — an estimated $1.22K sold.

Montag & Associates first reported a position in EXAS in Q4 2020 and held it in 21 quarters. The position peaked at $164K in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Montag & Associates reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Montag & Associates sold 12 Exact Sciences shares in Q1 2026, an estimated $1.22K.
  • Montag & Associates first reported a position in Exact Sciences in Q4 2020 and held it in 21 quarters.
  • Montag & Associates's Exact Sciences position peaked at $164K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.